[PDF] Top 20 Progesterone Receptor Activation. An Alternative to SERMs in Breast Cancer
Has 10000 "Progesterone Receptor Activation. An Alternative to SERMs in Breast Cancer" found on our website. Below are the top 20 most common "Progesterone Receptor Activation. An Alternative to SERMs in Breast Cancer".
Progesterone Receptor Activation. An Alternative to SERMs in Breast Cancer
... Published in: European Journal of Cancer (2000), ...version) Progesterone receptor activation: an alternative to SERMs in breast cancer ... Voir le document complet
2
Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
... by progesterone‟ hypothesis The main evidence advanced in support of the hypothesis is the finding that the proliferation of breast epithelium increases in luteal phase, reaching a peak 9–10 ... Voir le document complet
19
AXL receptor tyrosine kinase in breast cancer : defining novel substrates and pathways involved in cell motility and invasion
... leads to changes in ELMO ...proposed to be in a closed conformation and physically bound to DOCK proteins which are also in a closed conformation (Figure ...ELMO to ... Voir le document complet
238
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway
... belongs to the IL- 17 cytokines family and binds to IL-17 receptor B ...prognosis in patients with breast cancer and that IL-17B expression upregulation is specifically ... Voir le document complet
14
The human epidermal growth factor receptor 2 (HER2) in the breast cancer : from measurement to targeted treatment
... factor receptor 2 (HER2) is a transmembrane tyrosine kinase receptor belonging to the family of epidermal growth factor receptors (EGFR) ...is an essential mediator of cell proliferation and ... Voir le document complet
334
Human breast cancer cells educate macrophages toward the M2 activation status
... Immunohistopathological breast carcinoma studies with restricted numbers of samples (n = 53 and 120, respectively) reveal a gradual increase in the amount of infiltrating macrophages (CD68 + ) from normal ... Voir le document complet
15
Transcriptional Repression of Estrogen Receptor α Signaling by SENP2 in Breast Cancer Cells.: ERα repression by SENP2
... displayed an activation effect on both AR and ERR -dependent transcriptional activity (Supplementary Figure ...1C). To do so, MCF7 cells were transfected with the CFP or CFP-SENP2 expression plasmid ... Voir le document complet
15
Breast cancer care compared with clinical Guidelines: an observational study in France.
... related to the patient and her social status [1,14,15], to the tumour [6,7,15-18] and to the healthcare system ...hormonal receptor sta- tus (oestrogen or progesterone receptors ... Voir le document complet
10
Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
... sensitivity to these therapies of a subset of luminal tumors, as well as the secondary resistance which sets in after an initial response, prevent the cure of patients from their cancer by ... Voir le document complet
15
Magi1, a new potential tumor suppressor gene in estrogen receptor positive breast cancer
... Breast cancer (BC) is a heterogeneous disease that differs at the genetic, histopathological and clinical levels [ 12 ...Estrogen/Progesterone Receptor positive (ER + /PR + ), Human Epidermal ... Voir le document complet
23
Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: Synthesis and biological behaviour
... targeted to the receptor binding site, and to add a functional or potentially functional group to tamoxifen, in this case an organometallic function, that might lead to ... Voir le document complet
37
Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
... human breast cancer cell line (American Type Culture Collection) has been previously described (Khan et ...PRA in the presence of RSL1, or PRB in the presence of doxycycline in a ... Voir le document complet
36
Progesterone receptor, obesity and prognosis in women diagnosed with estrogen receptor positive breast cancer
... evidence to support the presence or absence of an association is rather weak for several molecular subtypes due to the single study, the positive but not significative associations or half of the ... Voir le document complet
79
Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.
... of breast cancer (2, ...conducted in Asia generally confirmed that a high consumption of soy-based foods and isoflavones is associated with a lower risk of premenopausal breast cancer, ... Voir le document complet
18
Coxsackie and adenovirus receptor is a target and a mediator of estrogen action in breast cancer
... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ... Voir le document complet
33
Using CommonKADS to Build an Expertise Model for Breast Cancer Prognosis and Therapy
... Introduction to conceptual modelling in breast cancer ...Introduction to some oncologic problems Cancer is a group of more than 100 different ...diseases. Cancer occurs ... Voir le document complet
105
Peroxisome proliferator-activated receptor-γ activation induces 11β-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophages.
... β To determine whether 11 -HSD1 is a direct PPAR target gene, the human 11 -HSD1 promoter was analyzed β β in silico ...performed to examine whether the PPAR -RXR heterodimer binds to – this ... Voir le document complet
12
The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
... alters breast cancer cell cycle progression IHC for Ki-67 was performed on the diagnostic biopsy (before treatment with propranolol) and on the tumor tissue from the radical mastectomy (after 25 days of ... Voir le document complet
12
Implicating the mechanisms of ADP-ribosylation factor activation in the resistance of invasive breast cancer cells to EGFR tyrosine kinase inhibitors
... cells to acquire new properties and decreased inhibitor ...act to relay signals between a cell and its ...message to the nucleus through the activation of signaling ...the receptor ... Voir le document complet
270
JAB1 Interacts with Both the Progesterone Receptor and SRC-1
... HAL Id: hal-03211045 https://hal.archives-ouvertes.fr/hal-03211045 Submitted on 28 Apr 2021 HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether ... Voir le document complet
11
Sujets connexes